Who suffers from postpartum depression?
And the pill will only be able to help people who receive a diagnosis and a prescription first. The symptoms of postpartum depression are not always easily recognized by new mothers, family members, and doctors. There is no test to predict who will develop it, but Payne's research has found that the risk is highest among first-time mothers , those under 25, and mothers of twins . Low-income mothers and women of color are also more at risk for postpartum depression, and less likely to receive health care. We wait to see who gets sick and then we treat," Payne clarifies. Judite Blanc, an associate professor of psychiatry and behavioral sciences at the University of Miami Miller School of Medicine, believes a pill is not a magic bullet because it only addresses the chemical component of postpartum depression, not the risk factors. , such as lack of social support or bad relationships.
To me, the rise of postpartum depression in modern society is a reflection of all the social pressures and demands that fall on women's shoulders ," she says, adding that mothers need help with the demands of child care. children. "We need a profound transfo Phone Number List rmation of society," she concludes. Quick relief from depression Compared to current antidepressants, zuranolone is also fast-acting . A class of antidepressants called selective serotonin reuptake inhibitors , or SSRIs, may be effective in treating postpartum depression, but they may take weeks or months to take effect. These drugs work by increasing the levels of the neurotransmitter serotonin in the brain. Many people who take traditional antidepressants do so for several years, and some may not benefit from the first drug they are prescribed, so they may have to try others until they find one that works. "This can greatly delay adequate treatment for these women," adds Díaz.
http://www.vietnamdata.co.uk/wp-content/uploads/2024/03/Phone-Number-List-.png
In contrast, zuranolone may begin to relieve symptoms after just two doses . "One of the strengths of this compound is its rapid onset of action," says Kimberly Yonkers, professor and chair of psychiatry at UMass Medical School and UMass Memorial Medical Center. "Postpartum depression can last months, even a few years, after giving birth, and it is unknown whether symptoms will return after a two-week treatment with the drug. There is also a risk of them suddenly losing consciousness while it is being administered, which is why it is only available in certain qualified healthcare facilities. Notably, no participants in the zuranolone trials have experienced loss of consciousness, which is crucial as the ideal treatment would be one that could be taken at home. Zobeida Diaz, a perinatal psychiatrist at Women and Infants Hospital in Rhode Island, says the hospital has administered Zulresso to about 60 patients since its approval and has seen very positive results. "But the problem is that having to admit someone for an intravenous infusion in the hospital creates a barrier for most women to receive this treatment," she explains, adding that a pill would open access to many more patients.
頁:
[1]